Tranexamic Acid fails to increase incidence of same-day discharge among Holmium Laser Prostate Surgery patients
U.S.A.: The inclusion of Tranexamic Acid (TXA) did not increase the incidence of same-day discharge or decrease the risk of complications in patients receiving HoLEP, according to prospective randomized research published in the Journal of Endourology.
To stop bleeding during orthopedic surgeries, tranexamic acid (TXA), a clot-promoting drug, is used. TXA has advantages in percutaneous surgery, according to urologists. Surgery for benign prostatic hyperplasia might cause hematuria, which could delay discharge or need ER visits.
The outcomes of same-day holmium laser enucleation of the prostate (HoLEP) were examined, and the influence of the addition of a single dosage of tranexamic acid (TXA) was assessed in this study.
110 patients receiving HoLEP were prospectively randomized from September 2021 to January 2022 to receive either 1 gram of TXA following induction or no treatment at all. Rate of successful same-day (SDD) discharge was the primary result. The transfusion rate, same-day catheter removal, length of stay (LOS), and 90-day complications were considered secondary outcomes. 110 individuals should be enrolled, according to power analysis, to detect a 25% difference in the SDD rate.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.